Skip to main content
News Directory 3
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
DR Vaccine Pneumococcal Disease News - News Directory 3

DR Vaccine Pneumococcal Disease News

October 9, 2025 Jennifer Chen Health
News Context
At a glance
  • The Dominican Republic's adoption of Prevenar 20 is a notable step in public health.
  • pneumococcal disease is caused by‍ the bacterium Streptococcus pneumoniae, which has over 90 different serotypes.
  • Note: Serotype coverage can vary depending on geographic location and circulating strains.
Original source: news.google.com

Pneumococcal ‍Vaccine Update

  • What: the⁣ Dominican Republic ‍(DR) has⁢ introduced a ‍new⁤ vaccine, Prevenar 20, to combat ‍pneumococcal diseases.
  • Where: Dominican Republic
  • When: ⁤ Announced February 29, 2024. Prevenar 20⁤ has also been added to⁤ the national vaccination schedule.
  • Why ⁣it‍ Matters: Pneumococcal diseases can cause serious illnesses like pneumonia, meningitis, and ear infections, ⁣particularly ⁣in young children and the elderly. Prevenar 20 offers broader protection against⁤ pneumococcal serotypes than previous vaccines.
  • What’s Next: Implementation of ⁤the new vaccine into the national vaccination program, increasing protection against pneumococcal ⁣diseases across the population.

The Dominican Republic’s adoption of Prevenar 20 is a notable step in public health. Pneumococcal disease remains ⁤a ⁤significant health burden globally, and expanding vaccine coverage with a more extensive vaccine like ⁢prevenar 20 is ⁤crucial.The inclusion in the national schedule ensures wider access and sustained protection.this⁤ move aligns with global efforts to reduce the incidence of invasive pneumococcal disease and ⁢its associated complications.

– drjenniferchen

Pneumococcal Serotypes⁤ & Vaccine Coverage

pneumococcal disease is caused by‍ the bacterium Streptococcus pneumoniae, which has over 90 different serotypes. Vaccines target specific serotypes, and the effectiveness of a ⁢vaccine ⁢depends on how well its serotype coverage matches the circulating strains in a given region.

Vaccine Serotype ‍Coverage (Approximate) Valency (Number ⁢of Serotypes)
Pneumococcal conjugate Vaccine (PCV13) ~85-90% (in many regions) 13
Pneumococcal Polysaccharide Vaccine (PPSV23) ~70-80% 23
Prevenar 20 ~86% 20

Note: Serotype coverage can vary depending on geographic location and circulating strains. Prevenar 20 includes serotypes not covered by PCV13, offering broader protection.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

More on this

  • Start Your Day With Protein And Fiber
  • Cholesterol Medication Reveals New Potential in Reducing Environmental Pollutants

Related

Search:

News Directory 3

News Directory 3 catalogs US newspapers, news services, newsstands and digital news outlets across all 50 states. Browse local publishers by city, state, or topic, and follow current headlines linked back to their original sources.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

© 2026 News Directory 3. All rights reserved.
For contact, advertising, copyright, issues email: office@newsdirectory3.com